FDA approves Merck RSV shot for infants to rival Sanofi AstraZeneca
The Food and Drug Administration on Monday approved Merck’s shot designed to protect infants from respiratory syncytial virus during their…
The Food and Drug Administration on Monday approved Merck’s shot designed to protect infants from respiratory syncytial virus during their…
Sanofi (NASDAQ:SNY)’s shares fell 5% this week, even as the company announced positive results from its AERIFY-1 trial with Regeneron…
By Dominique Patton and Geert De Clercq PARIS (Reuters) -France’s Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for…